Nicole Ullrich, MD, PhD
Professor of Neurology
A Review of Chronic Leukoencephalopathy among Survivors of Childhood Cancer.
Partap S, Russo S, Esfahani B, Yeom K, Mazewski C, Embry L, Wheeler G, Ullrich NJ, Bowers DC.
Pediatr Neurol. 2019 Dec;101:2-10. doi: 10.1016/j.pediatrneurol.2019.03.006. Epub 2019 Mar 21. PMID: 31047756
Health Supervision for Children With Neurofibromatosis Type 1.
Miller DT, Freedenberg D, Schorry E, Ullrich NJ, Viskochil D, Korf BR; COUNCIL ON GENETICS; AMERICAN COLLEGE OF MEDICAL GENETICS AND GENOMICS.
Pediatrics. 2019 May;143(5):e20190660. doi: 10.1542/peds.2019-0660. PMID: 31010905
Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma.
Plotkin SR, Duda DG, Muzikansky A, Allen J, Blakeley J, Rosser T, Campian JL, Clapp DW, Fisher MJ, Tonsgard J, Ullrich N, Thomas C, Cutter G, Korf B, Packer R, Karajannis MA.
J Clin Oncol. 2019 Dec 10;37(35):3446-3454. doi: 10.1200/JCO.19.01367. Epub 2019 Oct 18. Erratum in: J Clin Oncol. 2020 Feb 20;38(6):656. Erratum in: J Clin Oncol. 2020 Feb 20;38(6):656. PMID: 31626572
A Review of Chronic Leukoencephalopathy among Survivors of Childhood Cancer.
Partap S, Russo S, Esfahani B, Yeom K, Mazewski C, Embry L, Wheeler G, Ullrich NJ, Bowers DC.
Pediatr Neurol. 2019 Dec;101:2-10. doi: 10.1016/j.pediatrneurol.2019.03.006. Epub 2019 Mar 21. PMID: 31047756